DE2204361A1 - Neue pregnansaefre-derivate - Google Patents

Neue pregnansaefre-derivate

Info

Publication number
DE2204361A1
DE2204361A1 DE2204361A DE2204361A DE2204361A1 DE 2204361 A1 DE2204361 A1 DE 2204361A1 DE 2204361 A DE2204361 A DE 2204361A DE 2204361 A DE2204361 A DE 2204361A DE 2204361 A1 DE2204361 A1 DE 2204361A1
Authority
DE
Germany
Prior art keywords
methyl
acid
pregnadiene
dioxo
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2204361A
Other languages
German (de)
English (en)
Inventor
Erich Dr Gerhards
Helmut Dr Hofmeister
Karl Heinz Dr Kolb
Henry Dr Laurent
Klaus Dr Mengel
Klaus Dr Prezewowsky
Rudolf Dr Wiechert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to DE2204361A priority Critical patent/DE2204361A1/de
Priority to GB829972A priority patent/GB1387911A/en
Priority to DD72161068A priority patent/DD95565B1/de
Priority to YU443/72A priority patent/YU35148B/xx
Priority to CS8152A priority patent/CS174841B2/cs
Priority to IE227/72A priority patent/IE36120B1/xx
Priority to DK86472A priority patent/DK136612C/da
Priority to CH264772A priority patent/CH589671A5/xx
Priority to AT151372A priority patent/AT323342B/de
Priority to CH395876A priority patent/CH588509A5/xx
Priority to EG69/72A priority patent/EG10635A/xx
Priority to CS1214A priority patent/CS174827B2/cs
Priority to BE779869A priority patent/BE779869A/xx
Priority to PL15368972A priority patent/PL82283B1/pl
Priority to ES400163A priority patent/ES400163A1/es
Priority to NO581/72A priority patent/NO138808C/no
Priority to FI720497A priority patent/FI51103C/fi
Priority to FR7206522A priority patent/FR2156518B1/fr
Priority to IL39735A priority patent/IL39735A/xx
Priority to HUSCHE398*1A priority patent/HU165261B/hu
Priority to US00284710A priority patent/US3824260A/en
Priority to LU66213A priority patent/LU66213A1/xx
Priority to RO7272410A priority patent/RO71183A/ro
Priority to RO7284617A priority patent/RO70725A/ro
Priority to NLAANVRAGE7213456,A priority patent/NL179059C/xx
Priority to NL7213454A priority patent/NL179286C/xx
Priority to JP47100273A priority patent/JPS5837320B2/ja
Priority to CA153,227A priority patent/CA978518A/en
Publication of DE2204361A1 publication Critical patent/DE2204361A1/de
Priority to AT147074A priority patent/AT333989B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
DE2204361A 1971-10-04 1972-01-27 Neue pregnansaefre-derivate Pending DE2204361A1 (de)

Priority Applications (29)

Application Number Priority Date Filing Date Title
DE2204361A DE2204361A1 (de) 1972-01-27 1972-01-27 Neue pregnansaefre-derivate
GB829972A GB1387911A (en) 1971-10-04 1972-02-23 Pregnane acid derivatives
DD72161068A DD95565B1 (de) 1971-10-04 1972-02-23 Verfahren zur herstellung neuer pregnansaeurederivate
YU443/72A YU35148B (en) 1971-10-04 1972-02-23 Process for obtaining pregnane acid derivatives
CS8152A CS174841B2 (US07922777-20110412-C00004.png) 1972-01-27 1972-02-24
IE227/72A IE36120B1 (en) 1971-10-04 1972-02-24 New pregnane acid derivatives
DK86472A DK136612C (da) 1971-10-04 1972-02-24 Analogifremgangsmaade til fremstilling af 3,20-dioxo-4-pregnen-21-syrederivater
CH264772A CH589671A5 (US07922777-20110412-C00004.png) 1971-10-04 1972-02-24
AT151372A AT323342B (de) 1971-10-04 1972-02-24 Verfahren zur herstellung von neuen pregnansäure-derivaten
CH395876A CH588509A5 (US07922777-20110412-C00004.png) 1971-10-04 1972-02-24
EG69/72A EG10635A (en) 1971-10-04 1972-02-24 A process for preparation of pregnan derivatives used for treatment of local inflammation
CS1214A CS174827B2 (US07922777-20110412-C00004.png) 1972-01-27 1972-02-24
NO581/72A NO138808C (no) 1971-10-04 1972-02-25 Analogifremgangsmaate ved fremstilling av terapeutisk aktive pregnansyrederivater
PL15368972A PL82283B1 (US07922777-20110412-C00004.png) 1971-10-04 1972-02-25
ES400163A ES400163A1 (es) 1971-10-04 1972-02-25 Procedimiento para la preparacion de nuevos derivados de acido pregnanoico.
BE779869A BE779869A (fr) 1971-10-04 1972-02-25 Nouveaux derives d'acide de pregnane et leur procede de preparation
FI720497A FI51103C (fi) 1971-10-04 1972-02-25 Menetelmä tulehduksenvastaisten pregnaanihappojohdannaisten valmistami seksi.
FR7206522A FR2156518B1 (US07922777-20110412-C00004.png) 1971-10-04 1972-02-25
IL39735A IL39735A (en) 1971-10-04 1972-06-21 3,20-dioxo-pregn-4-ene-21-oic acid derivatives
HUSCHE398*1A HU165261B (US07922777-20110412-C00004.png) 1971-10-04 1972-06-21
US00284710A US3824260A (en) 1971-10-04 1972-08-30 Novel pregnanoic acid derivatives
LU66213A LU66213A1 (US07922777-20110412-C00004.png) 1971-10-04 1972-10-02
RO7272410A RO71183A (ro) 1971-10-04 1972-10-03 Procedeu de prepararea 20-on-steroidelor substituite
RO7284617A RO70725A (ro) 1971-10-04 1972-10-03 Procedeu de obtinere a derivatilor acidului pregnamic
NLAANVRAGE7213456,A NL179059C (nl) 1971-10-04 1972-10-04 Werkwijze ter bereiding van een geneesmiddel met ontstekingsremmende werking, gevormd geneesmiddel en werkwijze ter bereiding van geneeskrachtige verbindingen, geschikt voor gebruik bij deze werkwijze.
NL7213454A NL179286C (nl) 1971-10-04 1972-10-04 Werkwijze voor de bereiding van een geneesmiddel met ontstekingsremmende werking, gevormd geneesmiddel en werkwijze ter bereiding van geneeskrachtige verbindingen, geschikt voor gebruik bij deze werkwijze.
JP47100273A JPS5837320B2 (ja) 1971-10-04 1972-10-04 プレグナンサンユウドウタイ ノ セイホウ
CA153,227A CA978518A (en) 1971-10-04 1972-10-04 Process for preparing pregnane acid derivatives
AT147074A AT333989B (de) 1972-01-27 1974-02-22 Verfahren zur herstellung von neuen pregnansaure-derivaten

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2204361A DE2204361A1 (de) 1972-01-27 1972-01-27 Neue pregnansaefre-derivate

Publications (1)

Publication Number Publication Date
DE2204361A1 true DE2204361A1 (de) 1973-08-16

Family

ID=5834502

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2204361A Pending DE2204361A1 (de) 1971-10-04 1972-01-27 Neue pregnansaefre-derivate

Country Status (2)

Country Link
CS (2) CS174827B2 (US07922777-20110412-C00004.png)
DE (1) DE2204361A1 (US07922777-20110412-C00004.png)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215979A (en) * 1985-12-19 1993-06-01 Aktiebolaget Draco 16,17-acetalsubstituted pregnane 21-oic acid derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215979A (en) * 1985-12-19 1993-06-01 Aktiebolaget Draco 16,17-acetalsubstituted pregnane 21-oic acid derivatives

Also Published As

Publication number Publication date
CS174841B2 (US07922777-20110412-C00004.png) 1977-04-29
CS174827B2 (US07922777-20110412-C00004.png) 1977-04-29

Similar Documents

Publication Publication Date Title
DE69013957T2 (de) 3-Keto-Steroide mit einer Amino-substituierten 17-Kette, Verfahren zu deren Herstellung, Zwischenprodukte und pharmazeutische Präparate davon.
DD95565B1 (de) Verfahren zur herstellung neuer pregnansaeurederivate
CH634084A5 (de) Verfahren zur herstellung neuer kortikoide.
DE2150268C3 (de) Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2204361A1 (de) Neue pregnansaefre-derivate
DE2852055C2 (US07922777-20110412-C00004.png)
DE2150270C3 (de) Pregnansäure-Derivate und Verfahren zu ihrer Herstellung
DE2204358C2 (de) Verfahren zur Herstellung von Pregnansäure-Derivaten
EP0000471A1 (de) Neue Kortikoide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0149222A2 (de) Neue 6alpha, 16alpha-Dimethylkortikoide
DE2431292A1 (de) Neue carbazol-derivate
CH631997A5 (en) Process for the preparation of novel derivatives of 9-chloro-prednisolone
EP0032103B1 (de) Neue Kortikoid-17-thioacetale, ihre Herstellung und Verwendung
CH637407A5 (de) Verfahren zur herstellung neuer kortikoide.
DE2453823A1 (de) Neue methylensteroide
DE2448662C2 (de) 6α-Fluor-16α-methyl-1,4,8-pregnatrien-3,20-dion-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2204360C2 (de) Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2645105C2 (de) Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2209298A1 (de) Neue pregnansaeure-derivate
CH638226A5 (en) Derivatives of 9-fluoroprednisolone
AT373604B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
EP0012271B1 (de) Neue Prednison-Derivate, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Präparate und deren Verwendung
DE2742982C2 (de) 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2442616A1 (de) Neue d-homo-steroide
AT374204B (de) Verfahren zur herstellung von neuen kortikoiden

Legal Events

Date Code Title Description
OD Request for examination
OHW Rejection